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ABSTRACT
The human intestine hosts a diverse community of bacteria known as the intestinal
microbiota. The intestinal microbiota have a symbiotic relationship with the host
organism. Current research does not clearly define the effect these commensal
microorganisms have on the overall maintenance of gastrointestinal health, including
protection from the invasion and pathogenesis of foreign bacteria known as pathogens.
EHEC O157:H7 causes severe sickness and can be life-threatening, but is difficult to
study in vivo. One challenge is that EHEC does not colonize the preferred animal model
for human GI studies: the murine intestine. However, the murine pathogen Citrobacter
rodentium has been shown to colonize the mouse intestine and is used in current research
as a model for EHEC colonization and infection. However, no one knows how the
intestinal microbiota respond during the colonization C. rodentium and is addressed in
this thesis. The colonization of a streptomycin-resistant strain of C. rodentium was
observed over a 15-day period and quantified in both conventional and streptomycintreated mouse models using genus-specific primers and quantitative PCR. The day 7
results indicate that there is a significant increase of Bacteroidales in the uncolonized,
streptomycin-treated model, which is consistent with previous studies. The
characterization of the intestinal microbiota has yet to be fully described for the
colonization of C. rodentium in the mouse intestine as data analysis for this study
continues. The anticipated outcomes may lead to the prevention and clinical care of
EHEC on a global scale.
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The Gut Reaction: How the Intestinal Microbiota Respond to Colonization by
Citrobacter rodentium
INTRODUCTION
1. Gastrointestinal tract and its microbes
Gastrointestinal (GI) health is becoming increasingly popular in science and
health-related fields, especially concerning disease prevention and overall human health.
Within the GI tract exists a dynamic microcommunity that contains a diverse number of
species each with a unique role in maintaining the health of the host (1). This
microcommunity is known as the intestinal microbiota. At least 800 different bacterial
species comprise the intestinal microbiota with 1013 to 1014 total bacteria present at a
given time (2-4). The mutually beneficial relationship between the intestinal microbiota
and the host is not completely understood, although the interactions that exist microbe-tomicrobe as well as microbe-to-host may contribute to preventing disease and promoting
health (5). Effectively relating GI health to clinical practice is impossible without
understanding the basic nature, i.e. relationships among different microbes, genetic and
metabolic attributes, fluctuations occurring in the onset of infection, etc., of the microbial
community occupying the GI tract.
2. Models for study
A proper enteric model is needed to accurately study the dynamic interactions of
the intestinal microbiota. An in vivo model has proven superior to other modes of study
because it not only accounts for the physiological conditions of a real-life situation but
also for the anaerobic nature of the commensal gut bacteria (6). Rodents are used to
model the human GI tract because they share similar anatomical structures: both species
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have a duodenum, jejunum, large and small intestine, and cecum, although the cecum of
rodents is more pronounced than that of humans (7, 8). Rodents are preferred over other
mammals because their diet and environment are easy to control and monitor. In
addition, many research studies have obtained physiologically consistent results to those
observed in humans (9).
In current research, there exist three murine models to study the interactions
between a host and a given bacterium: gnotobiotic, conventional, and streptomycintreated. The efficacy and practical application to in situ conditions must be considered
when choosing a model. Gnotobiotic (germ-free) mice have no commensal microbes to
impede the introduction of an invading microbe into the system. In practical use, this
model is used to introduce specific elements back into a sterile system. However,
introducing a bacterial cocktail back into the GI tract post-infection does not account for
the complex interaction between a commensal microbial community and an invading
bacterium; elements of real-world situations are lost entirely. Thus, the gnotobiotic
mouse model may not be the model of choice for applications to clinical research in
relation to the other two models.
The conventional mouse model maintains the commensal microbial community
the gnotobiotic mice lacks. The presence of the normal gut microbiota makes the
conventional model ideal for studying pathogenesis; this model represents the conditions
that an invading microbe would face in situ. However, its use for other types of studies
(i.e. colonization studies) is limited for the same reason; the normal gut microbiota makes
the survival of a foreign microbe in the system difficult. Hence, the need exists for an in
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vivo model that allows for the introduction of an invading microbe into a system while
maintaining the physiological conditions of an in situ model.
Studies have shown that pre-treating mice with antibiotics (i.e. streptomycin)
allows for enteric pathogens to grow competitively within the mouse intestine, although
the mechanism by which this occurs is poorly understood (10, 11). It has been
hypothesized that streptomycin treatment decreases the intestinal mucosal layer of
commensal facultative anaerobes, freeing up nutritional niches, and vacating space (1214). In addition, streptomycin does not alter the mucosal layer of the GI tract as severely
as other antibiotics, which reduce the mucosal layer and in effect initiate a pathogenic
state (15). Many studies report only pre-treating mice with streptomycin and then
discontinuing the treatment for the rest of the study. These mice were asymptomatic in
the beginning of the study, but showed signs of pathogenesis at the end of the study.
Therefore, a given pathogen cannot be properly studied in the pre-pathogenic state with
pre-treatment alone.
Contrary to pre-treatment with streptomycin, continuous streptomycin treatment
maintains a pre-pathogenic state. Recent studies suggest that continuous streptomycin
treatment interferes with microbe-host interactions by increasing nitrate availability via a
slight inflammatory response, which may affect the persistence of the invading microbe
in the intestine (16, 17). Thus, the continuous streptomycin-treated mouse model is the
best model to describe how a foreign microbe maintains growth and survives within the
intestine without inducing pathogenesis (14, 18).
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3. Commensal bacteria within the intestine
In the intestine there exist a number of microhabitats where both commensal and
pathogenic bacteria reside. Commensal, non-pathogenic bacteria typically reside in two
places: either in the mucus layer covering the intestinal epithelial cells or in the luminal
contents. The intestinal epithelial cells secrete a mucus layer that covers the entire GI
tract. This mucus layer assumes an important role in maintaining and protecting both the
microbiota as well as the host cells from invading pathogens. In addition to acting as a
protective covering over the intestinal epithelia, the mucus layer separates the cell wall
of the intestine from the lumen, and serves as a source of nutrients for commensal strains
of bacteria (1, 6, 19). In general, the normal microbiota are found in the mucus layer
because they cannot maintain a growth rate equal to or greater than the turnover rate of
the intestinal epithelial cells (3). Sloughing and degradation of the mucus layer results in
the presence of commensal bacteria in the luminal contents, offering another form of
protection against invading microbes (19). Protection from invading microbes is the
basis of disease prevention, with the intestinal microbiota being the most fundamental
source of protection in the mammalian host.
4. Pathogenic bacteria within the intestine
In contrast to commensal bacteria, pathogenic bacteria are generally found in
close proximity to the intestinal epithelia; however, they do not necessarily grow faster
than either their commensal counterparts or the turnover rate of the intestinal epithelia.
The pathogenic nature of bacteria is a result of their ability to produce an array of
virulence factors otherwise lacking in commensal strains (20). Through the use of
virulence factors, pathogenic bacteria compromise the integrity of the intestinal epithelia;
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the physical separation of the luminal contents from the rest of the body is no longer
functional. Thus, disease is promoted throughout the host. The pathogenicity of a
foreign microbe to the host intestine is not only affected by its location within the
intestine, virulence factors, and genetic differences from commensal bacteria, but it is
also a function of the ability of a given pathogen to grow, survive, and maintain stable
existence in a particular niche of the intestine (3, 6).
5. Colonization within the intestine
Colonization may be described as the ability of a bacterium to compete for
nutrients and maintain a growth rate equal to or greater than the turnover rate of the
intestinal epithelia (8). The degree of pathogenicity of a given bacterium not only
depends on the virulence and successful competition for space, nutrients, and host
receptors of the bacterium but it also depends on its colonization success. Colonization is
the first step to pathogenesis, making the need for a suitable model of the colonization
period even more critical, especially as it relates to disease prevention (1, 21, 22).
6. Microbial composition in colonic mucus
Facultative anaerobes, including Escherichia coli, make up about 0.1% of the
intestinal microbiota (23). Escherichia coli is the most abundant facultative anaerobe
found in the mucosal layer of the intestine and is the most studied microorganism (6, 21).
Although it only makes up a small percentage of the total microbiota, E. coli is found in
nearly every mammal in similar abundances. The potential protective role of commensal
E. coli against pathogenic strains of E. coli has also been implicated (18).
The dominant enteric species inhabiting the large intestine include Bacteroides
spp., Bifidobacterium spp., Clostridium spp., Lactobacillus spp., and Enterococcus spp.,
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but their roles in the functional stability of the complex microbial community of the GI
tract is not well known (19). The populations of obligate anaerobes Bacteroides,
Clostridia and Bifidobacteria are not altered significantly when treated with
streptomycin, but the populations of Lactobacillus and facultative anaerobes typically
decreased under the same conditions (10). Bacteroides and Clostridium are the most
abundant obligate anaerobes, with Bacteroides having an eclectic composition of
different species (4).
7. Colonization resistance
Colonization resistance describes the challenge a microbe faces to colonize a
given system. The GI tract asserts a level of colonization resistance against foreign
bacteria via the function and presence of host commensal microbes. In the conventional
mouse model, commensal bacteria elicit host immunological responses via their
interaction with the intestinal epithelia to ward off infection by a foreign microbe, such as
pathogenic E. coli (24). In contrast, the streptomycin-treated mouse model eliminates
many factors impeding the colonization success of a given enteric pathogen. Factors
contributing to colonization resistance include competition for mucosal carbon sources
among commensal and pathogenic strains, competition for space, and respiration needs.
Some pathogens, such as Enteropathogenic E. coli, may overcome colonization resistance
via the utilization of multiple carbon sources and the co-metabolism of several carbon
sources to maintain colonization (25). Overcoming colonization resistance is necessary
for pathogenesis to ensue.
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8. Pathogenic Escherichia coli
Enteropathogenic Escherichia coli (EPEC) and Enterohemorrhagic Escherichia
coli (EHEC) are Gram-negative enteric pathogens. EPEC colonizes the small intestine
while EHEC colonizes the large intestine. In humans, EPEC and EHEC share many
virulent factors and can cause colitis with instances of bloody diarrhea (26). EHEC
O157:H7 causes life-threatening hemolytic uremic syndrome in humans, but exhibits
commensal-like behavior in cattle and streptomycin-treated mice (27). Also, EHEC
colonization is poorly understood partly due to its inability to colonize the conventional
mouse intestine (28). Its commensal-like behavior and its poor colonization present a
unique challenge for studying the colonization of EHEC O157:H7 in an animal model,
and, therefore, requires another means by which it can be studied in the mouse intestine.
9. Citrobacter rodentium as a model for EHEC
A member of Enterobacteriaceae, the enteric murine pathogen Citrobacter
rodentium is genetically similar to EHEC and EPEC, but does not induce pathogenesis in
humans (9, 29). However, it is considered highly infectious to mice. C. rodentium
targets the cecum and colon during infection and causes colonic hyperplasia (9). Not
only do genetic similarities exist between C. rodentium and EHEC and EPEC, but also
similarities in virulence factors (i.e. attachment mechanisms) have been observed among
the pathogenic strains (9, 30-32).
In mice infected with C. rodentium, the colonic response is similar to the response
induced in humans by EHEC infection (9, 30, 33); in short, C. rodentium is to mice what
pathogenic E. coli is to humans. However, the known virulence mechanisms of C.
rodentium in the murine intestine are not well-defined (32, 34). Because of its genetic
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and virulent similarities to EHEC, C. rodentium in the murine intestine serves as a
suitable model for EHEC in the human intestine. There is a gap in current research
regarding the microbial response to enteric colonization of EHEC and the potential role
of the intestinal microbiota in preventing the disease caused by the pathogen. I
hypothesize that Bacteriodales spp. and Clostridium spp. will have significantly altered
population abundances when streptomycin-treated mice are colonized with C. rodentium.
The results from this thesis will be the first time the bacterial community is quantified
and examined with the colonization and infection of C. rodentium in the streptomycintreated mouse model. Inferences may then be made concerning the interaction between
the human intestinal microbiota and pathogenic Escherichia coli. The anticipated
outcomes of this study may have applications in regard to future preventative measures
made in response to the global health threat and disease caused by EHEC.

MATERIALS AND METHODS
1. Conventional mouse model
The conventional mouse model was the model for studying the pathogenesis
induced by infection with C. rodentium. Three male, 6-week old CD-1 mice (Charles
River) were starved of food and water for 18-24 hours before being orally fed a 20%
sucrose suspension containing 105 CFU of C. rodentium strain DBS100 Strr
(streptomycin-resistant strain) (ATCC 51459). After the bacterial suspension was
ingested, food and water were returned ad libitum. Fecal samples were collected and
bacterial load was quantified 5 hours, 24 hours, and every other day post infection for 15
days. The mice were then euthanized by CO2 gas asphyxiation and cervical dislocation

THE GUT REACTION

12

before the ceca and colons were harvested. Three male, 6-week old CD-1 mice that were
not given the bacterial suspension served as controls.
2. Streptomycin-treated mouse model
The streptomycin-treated mouse was the model for studying the colonization of
the mouse large intestine by C. rodentium. Three male, 6-week old CD-1 mice (Charles
River) were given drinking water containing streptomycin-sulfate (5 g/L) to decrease the
resident facultative anaerobic microbiota. Mice were then starved of food and water for
18-24 hours before being orally fed a 20% sucrose suspension containing 105 CFU of C.
rodentium DBS100 Strr. After the bacterial suspension was ingested, food and
streptomycin water were returned ad libitum. Fecal samples were collected, bacterial
load was quantified, and mice were euthanized as was done with the conventional mice.
Three male, 6-week old CD-1 mice that were treated with streptomycin and not given the
bacterial suspension served as controls.
3. CFU determination
To determine the number of colony forming units (CFU), the fecal samples were
homogenized and serially diluted in 1 mL of 1% tryptone broth for every 0.1 g feces, and
plated on MacConkey agar containing streptomycin only (100 µg/ml). The fecal plates
were incubated overnight at 37°C, and bacterial colonies were counted the following day.
Colonies that were round with a red center and white rim were identified as C. rodentium.
In reality, fecal samples contain a smaller amount of the population of interest when
compared to cecal samples; however, collecting fecal samples is standard procedure for
bacterial quantification and is less intrusive compared to cecal sampling (35). The log10
mean number of CFU per gram of feces for either strain in the mice was calculated for
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each time point. The statistical significance for each CFU/g feces result was determined
using a Student’s t test (two-tailed with unequal variance).
4. Fecal genomic DNA isolation
Genomic DNA was extracted from the collected fecal samples from days 1, 3, 7,
and 15 of the colonization period using the QIAamp DNA Stool Mini Kit (Catalog
#51054) (Qiagen) according to the manufacturer’s instructions. Genomic DNA
concentration was determined at a wavelength of 260 nm using a NanoDrop 2000
Spectrophotometer (Thermo Scientific).
5. Relative quantitative PCR of genomic DNA
Relative quantitative PCR (qPCR) was employed using SsoFast EvaGreen
SuperMix (Bio-Rad #172-5201) and the primers listed in Table 1 for the day 7 samples
for both control and experimental groups. qPCR was performed with cycles consisting of
95°C for 15 min and 40 cycles of 94°C for 15 s, 60°C for 30s, and 72°C for 30 s (15).
qPCR was performed first on pure cultures to test the accuracy of the primers. The start
of amplification was recorded at a particular cycle number (Cq) for each genus, and the
Cq value for the Eubacteria (total bacteria) was used a standard against the specific
bacterial abundances. The change in Cqs (∆Cq) was determined and was then used to
calculate the relative population abundance by raising 2 to the -∆Cq.

RESULTS
1. Colonization Results
The genotypic and phenotypic profiles of the gastrointestinal microbiota may be
altered by changes occurring in the intestinal microenvironment. The introduction and
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Table 1. Quantitative PCR Primers
Target 16S rRNA

Primer

Sequence

Reference

Eubacteria (total

UniF340

ACTCCTACGGGAGGCAGCAGT

(15)

bacteria)

UniR514

ATTACCGCGGCTGCTGGC

Bacteroidales

BactF285

GGTTCTGAGAGGAAGGTCCC

UniR338

GCTGCCTCCCGTAGGAGT

Clostridium

UniF338

ACTCCTACGGGAGGCAGC

coccoides

CocR491

GCTTCTTAGTCAGGTACCGTCAT

Lactobacillus

LabF362

AGCAGTAGGGAATCTTCCA

LabR677

CACCGCTACACATGGAG

Coli F

GTGCCAGCMGCCGCGGTAA

Coli R

GCCATAACGTTGAAAGATGG

Bif164F

GGGTGGTAATGCCGGATG

Bif662R

CCACCGTTACACCGGGAA

Enterobacteriaceae

Bifidobacterium

(15)

(15)

(15)

(36)

(15)
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colonization of C. rodentium strain DBS100 may be considered an important change in
the intestinal microcommunity; this change as well as other physiological conditions may
affect its colonization in vivo. Therefore, the pathogenesis and colonization of
Citrobacter rodentium strain DBS100 Strr were observed by using both conventional and
streptomycin-treated mouse models over a 15-day period. The log CFU/g feces during
the C. rodentium DBS100 Strr colonization assay of both experimental groups were
determined (Figure 1). The degree to which each respective strain colonized the intestine
was assessed via the number of CFUs that persisted in the feces.
The first day shows no statistical difference in log CFU/g feces between the
conventional and streptomycin-treated models. However, a significant divergence
between the two models is observed beginning at day 7 and continuing to day 15 of the
experiment (Figure 1). Quantifying the population abundance of the most prominent
bacteria in the intestinal microbiota will increase the understanding of the colonization
results and the role the bacterial community has in the infection with C. rodentium strain
DBS100 Strr.
2. Relative qPCR results for day 7
To describe the gastrointestinal community dynamics associated with day 7 of the
colonization period, relative qPCR was used with genera-specific primers of the bacterial
16S rRNA gene (Table 1). The respective bacterial population abundances were
normalized to the total bacteria 16S rRNA gene copies in each sample. The
Bacteroidales population was significantly higher in the streptomycin-treated mouse
control compared to the conventional control, having over a three-fold increase in
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Figure 1. The colonization of C. rodentium strain DBS100 Strr in conventional and
streptomycin-treated mice. The log CFU/g of feces for both groups are nearly
indistinguishable for day 1 and then begin to display a significant difference on day 7,
with the conventional mice having significantly higher colonization than the
streptomycin-treated mice by the end of the colonization period.
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the streptomycin-treated intestine. There was a five-fold increase in Bacteroidales
population abundance in the colonized, conventional model versus its control, and nearly
a two-fold increase in the colonized, streptomycin-treated intestine versus its control
(Figure 2). However, neither one of these results are considered significant differences.
The Clostridia population had a two-fold decrease in the streptomycin-treated intestine
control versus the conventional control (Figure 3). There was not a significant increase in
population abundance in the colonized, conventional model, and less than a two-fold
increase in the streptomycin-treated mouse model. Neither the conventional nor the
streptomycin-treated mouse intestine had significant Clostridia differences with the
colonization of C. rodentium when compared to their respective controls. Also,
Clostridia population abundances in the presence of C. rodentium did not alter
significantly with the antibiotic treatment (Figure 3).
The Lactobacilli population abundance did not change with antibiotic treatment
alone (i.e. the controls had almost the same abundance). The conventional group
colonized with C. rodentium had a significant increase of over seven-fold compared to its
control, and a four-fold increase compared to the streptomycin-treated group colonized
with C. rodentium (Figure 4). The Bifidobacteria population did not display a
significance difference between the control groups or between the streptomycin-treated
control and the colonized streptomycin-treated mouse intestine (Figure 5). The
Enterobacteriaceae population abundances did not significantly differ between any of the
experimental groups, including the controls (Figure 6). Figure 7 displays the collective
relative abundances of each of the chosen genera.
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Figure 2. The bacterial abundance percentage for Bacteroidales. Quantitative PCR of
Bacteroidales populations using group-specific primers on DNA extracted from fecal
samples. The abundance of Bacteroidales was normalized to the total bacterial 16S rRNA
gene copies in each sample. Results had n = 3 mice per group. Student’s t-test reveals a
significant difference between control groups (P<0.05). Error bars represent standard
errors of the mean (SEM).
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Figure 3. Bacterial abundance percentage of Clostridium. Quantitative PCR of
Clostridia populations using group-specific primers on DNA extracted from fecal
samples. The abundance of Clostridia was normalized to the total bacterial 16S rRNA
gene copies in each sample. Results had n = 3 mice per group. Student’s t-test reveals no
significant difference between control groups or between the colonized/streptomycin
model (P>0.05). Error bars represent SEM.
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Figure 4. The bacterial population percentage of Lactobacilli. Quantitative PCR of
Lactobacilli populations using group-specific primers on DNA extracted from fecal
samples. The abundance of Lactobacilli was normalized to the total bacterial 16S rRNA
gene copies in each sample. Results had n = 3 mice per group. Student’s t-test reveals no
significant difference between control groups or between the experimental groups versus
their respective controls (P>0.05). Error bars represent SEM.
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Figure 5. The bacterial population percentage of Bifidobacterium. Quantitative PCR
of Bifidobacterium populations using group-specific primers on DNA extracted from
fecal samples. The abundance of Bifidobacteria was normalized to the total bacterial 16S
rRNA gene copies in each sample. Results had n = 3 mice per group. Student’s t-test
reveals no significant difference between control groups or between the experimental
groups versus their respective controls (P>0.05). Error bars represent SEM.
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Figure 6. The bacterial population percentage of Enterobacteriaceae. Quantitative
PCR of Enterobacteriaceae populations using group-specific primers on DNA extracted
from fecal samples. The abundance of target groups was normalized to the total bacterial
16S rRNA gene copies in each sample. Results had n = 3 mice per group. Student’s t-test
reveals no significant difference between control groups or between the experimental
groups versus their respective controls (P>0.05). Error bars represent SEM.
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Figure 7. The collective display of bacterial abundance percentages. Quantitative
PCR of select bacterial populations using group-specific primers on DNA extracted from
fecal samples. The abundance of target groups was normalized to the total bacterial 16S
rRNA gene copies in each sample. Error bars represent SEM.
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DISCUSSION
The goal of this study was to characterize the changes that occur among the
predominate genera of the intestinal microbiota in the presence of Citrobacter rodentium,
with the long-term goal of applying the results to clinical practice and disease prevention.
Unexpectedly, the colonization data revealed that C. rodentium DBS100 Strr was able to
colonize (i.e. maintain stable growth) better in the conventional model than in the
streptomycin-treated mouse intestine. The colonization of C. rodentium in the
conventional mouse intestine was unanticipated in consideration of previous studies,
which have shown that colonization of E. coli in the conventional model is not displayed
due to colonization resistance (37). Recall that the slight inflammatory response induced
by streptomycin treatment is a contributing factor to colonization success. The
colonization advantage observed in the conventional model of this project may be
explained by the inflammatory response previously observed in the intestines of
conventional mice infected with C. rodentium strain DBS100 (unpublished data). It was
observed that the enteric inflammatory response of the conventional mice was greater
than that observed in streptomycin-treated mice infected with the same bacteria. While
the exact source of inflammation in the conventional mouse is unknown, the response of
the intestinal microbiota to lipopolysaccharide has been implicated to induce an
exaggerated inflammatory response in humans (38). The reason for a colonization
advantage in the conventional model for C. rodentium is unclear in current research and
is beyond the scope of this study.
Concerning the control groups, the qPCR results are consistent with previously
published data that Bacteroidales populations are elevated with an approximately three-
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fold increase under streptomycin treatment (13). Curiously, the results indicate that there
was no significant change in any of the bacterial population abundances for the groups
colonized with C. rodentium in either model compared to their respective controls. Both
Bacteroidales and Clostridia bacteria maintained growth with the colonization of C.
rodentium even with antibiotic treatment (Figures 1 and 2). The day 7 results (Figure 4)
support the previously shown result that Lactobacilli are not significantly altered by
streptomycin treatment alone. The seven-fold increase of the Lactobacilli population
abundance in the colonized, conventional mouse intestine compared to its control has not
been observed in previous studies. Unfortunately, the dynamic relationship is not fully
understood between C. rodentium and Lactobacilli, and would be worth exploring in a
follow-up experiment. In the streptomycin-treated mouse intestine, the nearly two-fold
increase in Lactobacilli population abundance was not considered a significant change,
which was an expected result since streptomycin-treatment has not had any previous
indication of affecting the Gram-positive bacterial populations. However, this nearly
two-fold increase cannot be ignored as a change to the gut microbial composition for
future studies since the influence Lactobacilli have on the rest of the microbiota as well
as the host has not been described.
The results of this study indicate that the absence of antibiotic treatment in
addition to the presence of C. rodentium may have a direct impact on other factors
leading to the promotion of Gram-positive bacterial growth. The results of the Clostridia
and Bifidobacteria population abundances (Figures 2 and 5) do not support the
conclusion that all Gram-positive bacteria benefit (in terms of increased growth) from the
presence of C. rodentium in the absence (or presence) of continuous antibiotic treatment.
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To ensure the validity of the unpredicted finding of increased growth of Lactobacilli in
the conventional and not in the streptomycin-treated model compared to their respective
controls may warrant a repeated analysis of the genomic DNA with qPCR.
The colonization differences between EHEC and C. rodentium in the
conventional model cannot be fully explained by current research, but one contributing
factor may include the dynamic relationship between C. rodentium and the commensal
bacterial populations. Overall, the integrity of these results is called into question in part
because of the very low abundance percentage values; the collective population
abundances should comprise the majority of the microbial community. Notice in each
figure that the percentages do not sum to 100% (or even come close to this value). A
particular example proceeds from the low abundance percentage of Enterobacteriaceae
(Figure 6). Especially concerning the amplification of the DNA in the qPCR analysis,
there are many factors that could affect the results, including the purity of the genomic
DNA.
The microbial composition was defined for only day 7 of the colonization period,
but the changes in commensal bacteria abundances occurring for the entire duration of
the colonization experiment must be considered to better characterize the results shown in
Figure 1. The genomic DNA quantification of days 1 and 15 will spread light on the
bacterial population fluctuations and their contribution to the colonization differences
between both models throughout the 15-day colonization period, and is the goal of future
work for this study.
Notice that the colonization data from day 3 was not recorded; this was due to
misplating, resulting in undetermined CFUs. In addition, the genomic DNA from the day
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3 samples extraction is unreliable as the purity of the genomic DNA was compromised
during the extraction process. As a result, the day 3 colonization data was not recorded
and the quantification from day 3 will not be performed in the future.
The colonization results encourage histopathological scoring of the ceca and small
intestines of the mice under study. The histopathology scoring will elucidate whether or
not the colonization of C. rodentium caused colonic stress, especially that leading to the
pathogenesis phenotype. The ceca and colons of the mice used in this study have already
been isolated in preparation for the continuance of the project along the
immunohistochemistry branch.
Changes occurring in the Bacteroidales, Clostridia, and Enterobacteriaceae
population levels throughout the colonization period for the colonized, streptomycintreated mice when compared to the uncolonized, streptomycin-treated mice are expected
because of the antibiotic effect on facultative anaerobes. Based on the day 7 results,
significant fluctuations for the Lactobacilli population levels in the colonized,
streptomycin-treated mice when compared to the uncolonized, streptomycin-treated mice
are not anticipated. Altered population levels in the colonized, conventional mice when
compared to the uncolonized, conventional mice are expected for the five bacterial
genera under study, particularly with the Lactobacilli abundance. We expect a greater
significant change in bacterial population levels overall in the streptomycin-treated
mouse model in relation to the conventional mouse model. The divergence in
colonization of C. rodentium is not clearly explained by the present data, which further
emphasizes the need for the future quantification of all colonization samples of this
colonization experiment. The data obtained from the quantification of all of then samples
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will provide better insight into the interactions between the intestinal microbiota and the
colonization of C. rodentium in the conventional versus streptomycin-treated mouse
models.
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